Unique ID issued by UMIN | UMIN000028433 |
---|---|
Receipt number | R000032545 |
Scientific Title | Efficacy of capsule endoscopy in cirrhotic patients for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities |
Date of disclosure of the study information | 2017/07/28 |
Last modified on | 2017/07/28 20:17:39 |
Efficacy of capsule endoscopy in cirrhotic patients for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities
Capsule endoscopy and gastrointestinal lesions
Efficacy of capsule endoscopy in cirrhotic patients for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities
Capsule endoscopy and gastrointestinal lesions
Japan |
Esophageal varices requiring endoscopic therapies
Hepato-biliary-pancreatic medicine |
Others
NO
The aims of the current prospective interventional study are to investigate the diagnostic usefulness of capsule endoscopy for gastrointestinal lesions in liver cirrhosis patients with esophageal varices receiving endoscopic therapies.
Safety,Efficacy
Prevalence for small bowel lesions (small bowel lesions will be defined as follows: (a) vascular lesion or (b) ulcerative lesion). Tumor lesion will not be included for small bowel lesions in this study.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Device,equipment |
Capsule endoscopy for patiens with esophageal varices receiving endoscopic therapy
18 | years-old | <= |
Not applicable |
Male and Female
Patients with portal hypertension who were determined to be necessary for prophylactic endoscopic therapies for esophageal varices
(1)Patients aged less than 18 years
(2)Patients with gastrointestinal obstruction or fistula or those being suspected of having gastrointestinal obstruction or fistula
(3)Patients with gastrointestinal stenosis in whom capsule endoscopy will be remained in the same place.
(4)Patients with cardiac pacemakers or other implanted medical devices
(5)Patients with dysphagia
(6)Patients in whom consents for removal of remained CE are unable to be obtained
(7)Patients who are unable to receive open surgery
(8)Patients who were judged to be inappropriate for the study subjects
50
1st name | |
Middle name | |
Last name | Shuhei Nishiguchi |
Hyogo college of medicine
Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine
1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan.
0798-45-6472
kantan@hyo-med.ac.jp
1st name | |
Middle name | |
Last name | Yoshinori Iwata |
Hyogo college of medicine
Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine
1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan.
0798-45-6472
yo-iwata@hyo-med.ac.jp
Hyogo college of medicine
Hyogo college of medicine
Self funding
NO
2017 | Year | 07 | Month | 28 | Day |
Unpublished
Preinitiation
2017 | Year | 07 | Month | 19 | Day |
2017 | Year | 07 | Month | 27 | Day |
2017 | Year | 07 | Month | 28 | Day |
2017 | Year | 07 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032545
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |